| Alglucerase injection | Ceredase (Genzyme Corporation) | Long-term enzyme replacement therapy for children, adolescents and adult patients with a confirmed diagnosis of Type I Gaucher disease who
exhibit signs and symptoms that are severe enough to result in one or more of the following conditions:
a) moderate- | Daily Med MedlinePlus |
| Imiglucerase | Cerezyme® (Genzyme Corporation) | Enzyme replacement therapy in patients with type I Gaucher's disease. | Daily Med MedlinePlus |
| Miglustat | Zavesca® (Actelion Pharmaceuticals Ltd) | Treatment of mild to moderate Type I Gaucher disease in adults for whom enzyme replacement therapy is not a therapeutic option (e.g., due to constraints such as allergy, hypersensitivity, or poor venous access). | |